T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells

Bone Marrow Transplantation

Volumn 21, Issue 12, 1998, Pages 1183-1191

  Rondelli, D ^a,c   Anasetti, C ^b   Fortuna, A ^a   Ratta, M ^a   Arpinati, M ^a   Bandini, G ^a   Lemoli, R M ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alloreactivity; B7 1; B7 2; CD18; G CSF; Hematopoietic progenitors

Indexed keywords

B7 ANTIGEN; CD18 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; MONOCLONAL ANTIBODY;

ALLOIMMUNITY; APHERESIS; ARTICLE; BLOOD CELL; CELL STIMULATION; COLONY FORMING UNIT C; CONTROLLED STUDY; CULTURE MEDIUM; CYTOFLUOROMETRY; DILUTION; GRAFT REJECTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LEUKOCYTE CULTURE; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION; STEM CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

EID: 0031822078     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701259     Document Type: Article

References (25)

1. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994; 84: 2795-2801.
2. Baumann I, Testa NG, Lange C et al. Haemopoietic cells mobilised into the circulation by lenograstin as alternative to bone marrow for allogeneic transplants. Lancet 1993; 341: 369.
3. Sutherland HL Eaves CJ, Landsdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
4. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
5. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 1647-1654.
6. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
7. + blood cells. Blood 1996; 87: 4903-4909.
8. + peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy. Blood 1996; 88: 4132-4138.
9. Reisner Y, Itzigovitch L, Meshorer A, Sharon N. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. P roc Natl Acad Sci 1978; 75: 2933-2936.
10. Aversa F, Tabilio A, Terenzi A et al. Succesful engraftment of T cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84; 3948-3955.
11. + hematopoietic cells. Blood 1996; 88: 2619-2625.
12. Gerritsen WR, O'Reilly R. Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells. Blood 1994; 84: 1906-1912.
13. + hematopoietic progenitor cells by high gradient magnetic cell sorting (MACS). In: Hematopoietic Stem Cells. The Mulhouse Manual. Alpha Med Press: Dayton, OH, 1994, pp 201-213.
14. Lanier LL, O'Fallen S, Somoza C et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154: 97-105.
15. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614-1619.
16. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997; 89: 1189-1196.
17. + cells. Blood 1992; 80: 429-436.
18. Guinan EC, Gribben JG, Boussiotis VA et al. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84: 3261-3282.
19. Ellis JH, Burden MN, Vinogradov DV et al. Interactions of CD80 and CD86 with CD28 and CTLA-4. J Immunol 1996; 56: 2700-2709.
20. Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-413.
21. + bone marrow cells does not affect lineage commitment. Blood 1996; 87: 4120-4128.
22. Gribben JG, Freeman GJ, Boussiotis VA et al. CTLA-4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995; 92: 811-815.
23. + helper T cells. J Exp Med 1990; 171: 1315-1332.
24. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993; 177: 1791-1796.
25. Gribben JG, Guinan EC, Boussiotis VA et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool. Blood 1996; 87: 4887-4893.